BTRX Insider Trading Activity and SEC Form 4 Filings
BTRX insider trading summary
No open-market insider purchases or sales of Barrier Therapeutics Inc (BTRX) have been reported on SEC Form 4 in the past 12 months.
Latest BTRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 6, 2008 | Stiefel Laboratories, Inc. | Insider | Buy | $4.3M (1,033,464 @ $4.15) |
| Aug 6, 2008 | Bengal Acquisition Inc. | 10% Owner | Buy | $4.3M (1,033,464 @ $4.15) |
| Aug 6, 2008 | Charles W Stiefel | Insider | Buy | $4.3M (1,033,464 @ $4.15) |
| Aug 5, 2008 | Stiefel Laboratories, Inc. | 10% Owner | Buy | $142.2M (34,266,494 @ $4.15) |
| Aug 5, 2008 | Charles W Stiefel | Insider | Buy | $142.2M (34,266,494 @ $4.15) |
| Nov 13, 2006 | Edward L Erickson | Director | Buy | $2K (300 @ $7.25) |
| Nov 13, 2006 | Edward L Erickson | Director | Buy | $726 (100 @ $7.26) |
| Nov 13, 2006 | Edward L Erickson | Director | Buy | $7K (1,000 @ $7.20) |
| Nov 13, 2006 | Edward L Erickson | Director | Buy | $4K (600 @ $7.23) |
| Sep 27, 2006 | Charles F Jacey Jr | Director | Buy | $2K (300 @ $6.40) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.